Tracon Pharmaceuticals, Inc.·4

Jun 13, 8:04 PM ET

MATTINGLY MARTIN A 4

4 · Tracon Pharmaceuticals, Inc. · Filed Jun 13, 2018

Insider Transaction Report

Form 4
Period: 2018-06-13
Transactions
  • Award

    Director Stock Option (Right to Buy)

    2018-06-13+15,00015,000 total
    Exercise: $2.70Exp: 2028-06-12Common Stock (15,000 underlying)
Footnotes (1)
  • [F1]The shares subject to the option shall vest and become exercisable on the earlier of the first anniversary of the grant date set forth in column 3 above or the date of the next annual meeting of the Company's stockholders.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION